Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Ранг среди акций #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Цена акции
$0.1559364
Последняя синхронизация: 2026-09-18
Рыночная капитализация
$195.17K
Изменение (1 день)
6.60%
Изменение (1 год)
-30.91%
Страна
GB
Торговля Fusion Antibodies plc (FAB)

Категория

История цены акций Fusion Antibodies plc (FAB)
Наивысшая цена закрытия: $0.15 2026-09-01

Наименьшая цена закрытия: $2.40 2017-12-01
История цены акций Fusion Antibodies plc с 2017 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -10.83%
2025 153.72%
2024 39.11%
2023 -88.99%
2022 -66.99%
2021 -1.91%
2020 55.79%
2019 51.91%
2018 -71.85%
2017 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$509.53 32.99%
US
$991.92 34.63%
NL
$154.28 511.26%
US
$123.40 -5.68%
AU
$708.28 3.70%
CH